Ujin Pharma Limited Files DHRP for IPO
Mumbai, June 23, 2026: Mumbai-based Ujin Pharma Limited has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) to raise funds through Initial Public Offering (IPO). The IPO, with a face value of Rs 10, is a fresh issue up to 11,869,100 equity shares and an offer-for-sale up to 7,282,300 shares by promoters – Jinesh Rasiklal Sheth, and Umang Ketan Mehta. The proceeds from its fresh issuance worth Rs 61.7 crore will be utilised for investment in Altra Agro-Chem Private Limited - the company's associate company, by way of subscription to equity shares for making it their subsidiary, Rs 21.6 crore in investment in Altra Pharma-Chem Private Limited, their associate company, by way of subscription to equity shares for making it their subsidiary, Rs 25 crore for repayment or pre-payment, in part or full, of certain borrowings availed by the company from financial institutions, and general corporate purposes. The Of...